Compound reference
ARA-290
Also referenced as: Cibinetide
ARA-290 (Cibinetide) reference material: helix-B EPO-derived peptide chemistry, published ischemia-model research, purity/identity testing, and storage guidance.
Identity and class
Nonerythropoietic erythropoietin-derived peptide
A synthetic 11-amino-acid peptide derived from the helix-B region of erythropoietin (EPO), engineered to lack the erythropoietic activity of the parent molecule.
Molecular weight approximately 1400 Da range, consistent with an 11-residue peptide sequence.
Published research areas
The subject matter of published laboratory literature. Listed as what was studied — not as an effect, and not as a use in humans.
- Published laboratory studies have examined ARA-290 in renal ischemia/reperfusion tissue models.
- Research has examined the innate repair receptor pathway as a subject of study in nonerythropoietic EPO-derivative literature.
Handling and storage
- Supplied as a lyophilized powder.
- Manufacturer-recommended storage: -20°C for long-term storage, protected from light.
Citations
- ARA 290, a nonerythropoietic EPO derivative, in renal ischemia/reperfusion
Molecular Medicine · 2011